Brief: Iovance Biotherapeutics Q2 Revenue USD 99.313 Million
06/08/2026 12:02
BRIEF-Iovance Biotherapeutics Q2 Revenue USD 99.313 Million Aug 06 (Reuters) - Iovance Biotherapeutics Q2 net income USD -47.315 million vs. IBES estimate USD -57.6 million.
- Q2 operating income USD -51.905 million vs. IBES estimate USD -59.7 million
- Q2 pretax profit USD -48.688 million vs. IBES estimate USD -59.8 million
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies